Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?
Adam
Rene
R
Centre Hépato-Biliaire, Hôpital Paul Brousse, Assistance Publique-Hôpitaux de Paris, Univ Paris-Sud, UMR-S 776, Villejuif, France. rene.adam@pbr.aphp.fr
Bhangui
Prashant
P
Poston
Graeme
G
Mirza
Darius
D
Nuzzo
Gennaro
G
Barroso
Eduardo
E
Ijzermans
Jan
J
Hubert
Catherine
C
Ruers
Theo
T
Capussotti
Lorenzo
L
Ouellet
Jean-Francois
JF
Laurent
Christophe
C
Cugat
Esteban
E
Colombo
Pierre Emmanuel
PE
Milicevic
Miroslav
M
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015415:Biomarkers / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis; D016009:Chi-Square Distribution; D015179:Colorectal Neoplasms / Q000473:pathology*; D003131:Combined Modality Therapy; D005260:Female; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary* / Q000601:surgery*; D008297:Male; D016609:Neoplasms, Second Primary / Q000188:drug therapy* / Q000601:surgery*; D011183:Postoperative Complications; D011379:Prognosis; D016016:Proportional Hazards Models; D012042:Registries; D015996:Survival Rate
D015415:Biomarkers; D002272:Carcinoembryonic Antigen